During the First Innovative Enterprise Week in Riga, the EIB Group and the European Commission (EC) have launched three new financial products to boost the competitiveness of innovative companies in Europe under the “InnovFin – EU Finance for Innovators” programme.
JPIAMR particularly welcomes ‘InnovFin Infectious Diseases’ which will support that new drugs, vaccines and medical and diagnostic devices, also in the AMR field, are made available faster to people who need them. These financial products allow projects with a higher risk factor to receive loans. EUR 100m has been allocated initially to each of the three products to kick-start the initiatives.
Read press release
